Abstract
Respiratory infections are one of the top causes of death in the elderly population, displaying susceptibility factors with increasing age that are potentially amenable to interventions. We posit that with increasing age there are predictable tissue-specific changes that prevent the immune system from working effectively in the lung. This mini-review highlights recent evidence for altered local tissue environment factors as we age focusing on increased tissue oxidative stress with associated immune cell changes, likely driven by the byproducts of age-associated inflammatory disease. Potential intervention points are presented.
General Introduction
The elderly population will double to 2 billion by 2050 (Publications, 2019). Age-associated cellular decline begins to be notable in our 40s and accelerates in our 60s (; ; ; Schneider et al., 2021). While aging represents a complex progression involving many physiological and physical changes in metabolism and endurance, the field of aging is advancing steadily, with greater understanding of the changes in cellular processes, and the critical role that tissue-specific health plays in how we age. However, the molecular events driving age-dependent physiological and physical decline and the molecular thresholds at the tissue and cellular levels that determine the point(s) of no return or so-called tipping point(s), resulting in non-recoverable tissue or systemic dysfunction are largely unknown. Here, we will highlight how and when some aspects of age-associated cellular decline occur in the pulmonary space, a critical organ that interfaces directly with the environment and is prone to infections. Such information can help develop therapeutic strategies to enhance healthy pulmonary aging in a timely manner to mitigate or delay deleterious events.
The Lung Alveolar Environment During Aging
As we age, there are changes in the physical environment and mechanical function of the lung that influence breathing and contribute to the increased susceptibility of the elderly to many infections (Schneider et al., 2021; ; Vaz Fragoso and Lee, 2012; ). Aging-related changes in the respiratory system generally include structural changes in the thoracic cage and lung parenchyma, abnormal lung function including ventilation and gas exchange abnormalities, decreased exercise capacity, airway nerve impairment, and reduced respiratory muscle strength and elasticity; each of which affect the cough reflex, sneezing or breathing (Figure 1) (Schneider et al., 2021). These progressive changes cause a decline in lung function and impaired immunological responses (; ; Sharma and Goodwin, 2006; van Oostrom et al., 2018; ; Thomas et al., 2019; ; ). To avoid cumulative damage, lung-resident cells rely on a robust homeostatic balance of stress response and associated inflammatory pathways; however, there is likely a tipping point (Figure 2), where age-associated changes finally overwhelm these control mechanisms leading to an increasing oxidative environment and irreversible damage (; Schöttker et al., 2015; Schneider et al., 2021). These factors combined with reduced lung-specific homeostatic immune activities facilitate entry of pathogens into the upper and lower respiratory tract leading to an increased propensity for infection (Vaz Fragoso and Lee, 2012; ).
FIGURE 1
FIGURE 2
The Lung Mucosa
The alveolus is lined with lung mucosa, composed of a surfactant lipid layer and an aqueous-hypophase called alveolar lining fluid (ALF) (Torrelles and Schlesinger, 2017). ALF contains innate soluble components with the primary role of maintaining proper pulmonary function (Notter, 2000; ; Torrelles and Schlesinger, 2017). Our studies and others indicate that lung tissue in the elderly (in humans and mice) has a high basal inflammation and oxidative stress that leads to dysfunction of critical innate soluble and cellular components that could drive host susceptibility to respiratory infections and diseases [e.g., influenza, pneumonia, tuberculosis (TB)] (Toapanta and Ross, 2009; Shivshankar et al., 2011; ; ; Piergallini and Turner, 2018a; ; ; ). Thus, defining when and how these changes occur at the cellular and molecular level is critical to understand age-associated lung-specific pathologies and aging in general. Published studies demonstrate that the elderly have basal inflammation (e.g., elevated levels of TNF-α, IL-6, IL-1β, and IL-12), as well as increased protein oxidation with elevated levels of proteins with carbonyl and nitrotyrosine residues indicative of oxidation by reactive oxygen (ROS) and nitrogen (RNS) species, respectively, and reduced protein function in the lung (; ). Indeed, studies focused on studying the lung mucosa composition in the elderly showed increased levels of innate surfactant proteins and components of the complement system, but with diminished function (). Dysfunction of innate soluble components of the lung mucosa is linked directly to high levels of oxidative stress [(e.g., elevated levels of ROS/RNS and myeloperoxidase (MPO)], which impair their function, and oxidizes critical surfactant lipids involved in keeping the lung alveolar space integrity and functionality ().
Studies addressing the impact of the human lung mucosa from the elderly on microbial pathogenesis are very limited. Upon reaching the alveolar space, respiratory pathogens come in close contact with the lung mucosa before and after their encounter with host alveolar compartment cells [e.g., type 1 and 2 epithelial cells (ATs) and alveolar macrophages (AMs)]. Our previous studies show that homeostatic innate soluble components of the ALF can quickly alter the cell envelope surface of pathogens upon contact, influencing subsequent pathogen-host cell interactions and infection outcomes (; ; ; ; Scordo et al., 2017; Scordo et al., 2019; ). Alterations of a pathogen cell envelope is mainly due to homeostatic hydrolytic activities (hydrolases), primarily responsible for maintaining lung health, that modify pathogens and influence their subsequent interactions with host cells (; ; Torrelles and Schlesinger, 2017). In this context we have demonstrated that ALF from healthy 60 + year old individuals is dysfunctional, with loss of homeostatic hydrolytic capacity and impaired innate soluble responses linked to high local oxidative stress, compared to healthy 18- to 45-year-old individuals (). Importantly, a pathogen such as Mycobacterium tuberculosis exposed to ALF from the elderly demonstrates increased virulence in vitro and in vivo indicating that impaired innate responses in the lung may play a critical role in susceptibility to respiratory infection as we age (). In this context, two major cell populations in the alveolar space are AMs and ATs. Our studies indicate that after exposure to ALF from the elderly, M. tuberculosis doubles its intracellular growth rate in AMs, further indicating the impact of ALF dysfunction as we age (). Thus, efforts to mitigate oxidative stress in the lungs prior to a so-called tipping point(s) may reduce inflammation and aid in functional recovery of important innate immune-modulators against respiratory pathogens (Piergallini and Turner, 2018b; ; ).
Evidence for a higher oxidative environment of the elderly lung is also supported by proteomics studies in other tissues and in-vitro studies with purified mitochondria from old mice (; Stauch et al., 2015; ; ; ; Ubaida-Mohien et al., 2019; Yang et al., 2019). However, the mechanism behind elevated oxidative stress in the lungs as we age is still not completely understood. Based on studies in other tissues, the oxidative pulmonary environment may be attributed in part to mitochondrial dysfunction. Mitochondria are primarily responsible for producing ATP () and are found in greater numbers in tissues and organs where energy needs are high (e.g., muscle, heart, brain, liver and kidney). However, few studies have focused on the lung despite its direct exposure to oxygen, large consumption of energy (), and high risk of dysfunction and disease in older age as mitochondrial function declines (Short et al., 2005; ; ; Sekhar M.D. et al., 2019). Thus, interventions to address the management of mitochondria-induced oxidative stressors (e.g. reactive oxygen and nitrogen oxidative species, ROS, NOS) in the lung tissue should mitigate lung oxidative stress and inflammation, and lead to improved resistance of the elderly to respiratory infections.
Alveolar Macrophages During Aging
Aging is associated with a weakening of immune function, called cellular immunosenescence. In addition to this process there is a baseline level of dysfunctional inflammation in old age termed inflammaging (; ; ; ; ; ). The relationship between inflammaging and dysfunctional innate immunity is understood poorly, especially in the lung. These changes are thought to be critical to understanding why the elderly are at an increased risk of developing and succumbing to malignancies, autoimmunity (; Pawelec et al., 2010), and infectious diseases such as TB (Piergallini and Turner, 2018b; ; ).
AMs live in a unique tissue environment and we are only now gaining insight into the local environmental factors that impact AM phenotype and function (; ; ; Papp et al., 2018; ; ). AM responses enable us to maintain health (clearance of invaders) and at the same time, must dampen pro-inflammatory responses to maintain alveolar structure to enable gas exchange. Our failure to understand the cellular and molecular events underlying AM development and biology creates a critical barrier in our attempts to develop new treatment strategies that target the lung. AMs, which constitute >95% of the cells recovered by bronchoalveolar lavage in healthy individuals, are thought to play a central role in lung inflammaging due to their unique regulation by molecular factors in the lung environment.
Indeed, our studies and others have demonstrated an AM inflammatory signature in the elderly (; Wong et al., 2017; ; ). Specifically, AMs from old mice express higher mRNA levels of the macrophage migration inhibitory factor (MIF), TNF-α, IFN-β, IL-10, IL-12p40, and CCL2 than young mice, and old mice also contain higher levels of MIF, IL-1β, IFN-β, and CCL2 in their alveolar lining fluid. Further, old mice have two distinct AM subpopulations, a major CD11c+ CD11b− population and a minor CD11c+ CD11b+ population; the latter is increased significantly in old mice (∼4-fold). Expression of pattern recognition receptors, antigen presentation molecules, and activation markers such as CD206, TLR2, CD16/CD32, MHC class II, and CD86 is higher in CD11c+ CD11b+ AMs, and these cells express monocytic markers such as Ly6C, CX3CR1, and CD115, suggesting monocytic origin. Old mouse purified CD11c+ CD11b+ AMs phagocytose significantly more M. tuberculosis, and express higher RNA levels of genes favoring M. tuberculosis intracellular growth. Thus, the lungs of old mice contain two distinct AM subpopulations, a defined resident subpopulation and an immigrating CD11c+ CD11b+ AM subpopulation expressing monocytic markers, a unique inflammatory signature, with enhanced M. tuberculosis phagocytosis capacity and M. tuberculosis survival. Our findings suggest that this CD11c+ CD11b+ AM subpopulation could be targeted by respiratory pathogens as a niche for replication and survival within the lung of the elderly population driving their susceptibility to respiratory infections.
Nuclear receptors (NRs) function as cellular transcription factors enabling macrophages and other myeloid cells to sense their local environment and shape their immune and metabolic responses (; ; ). Drugs targeting NRs represent 16% of all drugs approved for sale in the United States in 2019, demonstrating their feasibility as host-directed therapies (HDTs) for disease management (Ricote and Glass, 2007; Santos et al., 2017; ; Zhang et al., 2020). NRs are increasingly appreciated for their importance during aging (Speeckaert et al., 2014; Paillasse and de Medina, 2015; ; Xu et al., 2020). Most past studies have focused on specific NRs in cell lines or murine cells, thus their function and interactions within primary cells and the lung environment are largely unexplored. Studies using human and murine macrophages (Zollner and Trauner, 2009; ; ; ; Ning et al., 2019; Zhao et al., 2019; Zhao et al., 2020) in cancer (Zhou et al., 2014; ; Zhao et al., 2019), auto-immunity (Zollner and Trauner, 2009; ; Ning et al., 2019; Olson et al., 2020) and infectious diseases (Renga et al., 2012; ; ) have highlighted the importance of NRs in maintaining tissue homeostasis (Nagy et al., 2013; Zhao et al., 2020; ). Several NRs are postulated to dampen pro-inflammatory networks (; ; ; ; Wang et al., 2017; ; Pulakazhi Venu et al., 2021; Vuttaradhi et al., 2021). Thus, NR dysfunction during aging may remove the brakes to pro-inflammatory and oxidative stress pathways with associated altered mitochondrial function as discussed above. Since NRs regulate metabolism and inflammation in a tissue-specific manner, studying NR expression and activity as well as their involvement in altering lung macrophage lipid metabolism, cellular energy homeostasis and protective immune responses during aging could help define new biological pathways that play important roles in host responses in the lung as we age.
One particularly important NR regulating AM development and function is peroxisome proliferator-activated receptor gamma (PPARγ), where our recent work has identified novel targetable PPARγ effectors that regulate inflammation and cell death pathways (). PPARγ endogenous ligands include eicosanoids, which are critical determinants of cellular metabolism and immune responses that exert both anti- and pro-inflammatory actions (; ; ; ), and likely play important roles in controlling cellular aging. Indeed, PPARs regulate gene expression through multiple mechanisms, including heterodimerizing with the retinoid X receptor (RXR), and binding to PPAR response elements in promoters. PPARs also trans-repress NF-κB and other transcription factors to negatively regulate pro-inflammatory pathways and stabilize the NR co-repressor NCoR, to repress gene expression (Ricote and Glass, 2007). Using macrophage-specific PPARγ knockout mice (Odegaard et al., 2007), we showed that PPARγ specifically in lung macrophages is important for controlling bacterial growth (e.g. M. tuberculosis) and limiting inflammation in vivo (). These findings highlight a critical role of PPARγ in controlling inflammation, yet the impact of aging on PPARγ and expression and activity of other NRs is still unclear.
Based on our knowledge in the field (Oren et al., 1963; O'Neill et al., 2016; Viola et al., 2019), several NRs are postulated to dampen pro-inflammatory networks (; ; ; Papi et al., 2014; ; ; ). Thus, it is plausible that NR expression and activity are altered across the continuum of age and NRs become dysfunctional; where age-related NR changes can induce aberrant lung macrophage inflammation, oxidative stress, lipid metabolism, and energy programs. Thus, modulation of NR activity with agonists or antagonists could restore healthy immune homeostasis to slow or reverse the lung health issues associated with aging, allowing for more robust protection against lung infections and inflammatory diseases.
Other Cellular Changes in the Alveolar Compartment During Aging
As we age, alveolar compartment cells become senescent due to the shortening of telomeres and the accumulation of DNA lesions driven by free oxidative radicals generated in the lung environment. AMs, interstitial macrophages, neutrophils and dendritic cells lose their microbicidal and antigen presenting capacities (Wenisch et al., 2000; Uyemura et al., 2002; Stout et al., 2005). Notably, neutrophils exhibit an alteration of their homeostatic functions that may contribute to the susceptibility to lung infections of the elderly (). These include decreased phagocytosis, reduced production of ROS and extracellular traps (NETS) formation (), as well as reduced apoptosis and chemotaxis accompanied with dysregulated migration (Niwa et al., 1989; ). Natural killer (NK) cells, which also constitute a first line of defense against virus-infected and malignant cells () change with age. In particular, NK cells become dysfunctional for secretion of regulatory and anti-microbial responses, cytotoxic capacity, and elimination of transformed and senescent cells (). These alterations have implications for age-associated immune responses in the alveolar space of elderly individuals. Indeed, several studies implicate NK dysfunction to increased cases of TB reactivation in the elderly, as well as poor resolution of inflammatory disorders and increased incidence of respiratory infections ().
With regard to adaptive immunity, the number of B cells decrease during aging leading to reduced immunoglobulin diversity and affinity (; ; ). Age associated inflammation is also known to impact B cell function (), impacting germinal center formation and cytokine mediated signaling. Systemic T cell proliferation is impaired, repertoire diversity decreases, homeostasis is modified, intracellular signal transduction capability is dysregulated, and T cells produce less cytokines and are less cytotoxic (; Voehringer et al., 2002; Ouyang et al., 2003; Naylor et al., 2005). Indeed, CD4 and CD8 T cells show age-related changes in function (; ; ), with changes in CD4 T cells during aging (; ) influencing both CD8 T function and B cell antibody production in response to influenza (; Toapanta and Ross, 2009; ). For CD4 T cells, intrinsic defects promote delayed adaptive immune responses and recovery from influenza infection, but adoptive transfer studies have also shown that extrinsic factors also contribute to poor T cell function in the lung. This eludes to the influence of the myriad of changes in the alveolar space, such as oxidation of innate molecules or altered AM function, with increasing age that have wide reaching effect including an influence on adaptive immune function. Significant to lung function in older age, memory T cell populations start to lose their function, most notable in tissue specific resident memory CD8 T cells (CD8 TRM cells) (Schenkel et al., 2014; ; ) (). CD8 TRM cells from old mice have been shown to drive lung fibrosis following influenza, SARS-CoV-2 and chikungunya infections, potentially via TGFβ, likely delaying recovering of lung function and promoting conditions for secondary infection and other age associated lung disorders (Uhrlaub et al., 2016; ; ; Shenoy and Mizgerd, 2021). Interestingly, within the lung environment, we have also shown that resident effector CD8+ T cells demonstrate a robust innate-like response, driven by an IL-12 dependent but antigen-independent secretion of IFNγ (Vesosky et al., 2006a; Vesosky et al., 2006b; Rottinghaus et al., 2009; Vesosky et al., 2009). Such CD8 effector cells were shown to play a role in early innate control of M. tuberculosis infection in old mice (Vesosky et al., 2006a; Rottinghaus et al., 2009; Vesosky et al., 2009). The relevance of such cells is not clear, but it is thought to be a compensatory mechanism to establish an additional defense barrier against respiratory pathogens in the elderly (Piergallini and Turner, 2018b), but could equally be one that interferes with optimal antigen specific immunity or perhaps contributes to lung tissue damage that has long term consequences on pulmonary function with increasing age. The study of adaptive immune cells specifically in the lung during aging, in the context of chronic disease such as chronic obstructive pulmonary disease or asthma, is an as yet understudied area () but lung tissue specificity and age-associated changes likely also play a contributing role to the ability of T and B cells to exert their immune control as we age.
Discussion
Aging is accompanied by a decline in immune efficacy resulting in increased vulnerability to infections. There is increasing evidence that immune dysfunction linked to exacerbated inflammatory reactivity is associated with failure in organ systems (ex: lung, brain, skeletal muscle) leading to functional decline, morbidity and mortality. Several of these syndromes and diseases such as frailty, dementia, cardiovascular disease and cancer, result in elderly persons being dependent on others for daily living. Immune decline occurs at different ages, and can be influenced by host genetics as well as external “perturbations” such as metabolic status (e.g., dysglycemia) and lifetime exposure to pathogens. The mechanisms underlying these alterations are poorly understood; where it is unclear which changes are primary consequences of aging, and which are compensatory. Furthermore, it is unclear if inflammaging begins in the periphery and spills over into organs such as the lung or vice versa. Answering these questions is critical for the development and implementation of therapeutics that delay, prevent or restore an individual’s age-related decrease in immunity, including its associated failure of organ systems. Elucidation of these interactions is best accomplished through longitudinal studies spanning decades, which are logistically challenging and costly. Alternatives are cross-sectional studies in individuals of all ages, or short longitudinal assessments of individuals challenged by an “insult” to their immune system that accelerates aging of their immune cells. These studies in humans present interpretation challenges due to high levels of variability in factors of interest that may underlie responsivity to challenges, for example patients with undiagnosed dysglycemia which is the most prevalent metabolic perturbation in the elderly (; Scordo et al., 2021).
We postulate that there is a gradual increase in inflammation and altered metabolism across the aging continuum, potentially initiated in the pulmonary space, which is directly exposed to environmental insults, that culminates in a cascade of organ and systemic dysfunctions, reaching a peak or tipping point(s) where inflammation and oxidation can no longer be reversed by interventions (Figure 2). Modulating cellular oxidative stress-related factors that occur during inflammaging in the alveolus prior to the tipping point(s) may allow for the restoration and maintenance of healthy immune and metabolic homeostasis during aging.
Statements
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
This work was supported by a National Institutes of Health-National Institute on Aging (NIA) program project grant JT (P01-AG051428).
Acknowledgments
We would like to thank our laboratory members for their dedication to research on aging.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AlatshanA.BenkőS. (2021). Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function. Front. Immunol.12, 630569. 10.3389/fimmu.2021.630569
2
AllardB.PanaritiA.MartinJ. G. (2018). Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection. Front. Immunol.9, 1777. 10.3389/fimmu.2018.01777
3
AndersonA. J.JacksonT. D.StroudD. A.StojanovskiD. (2019). Mitochondria-hubs for Regulating Cellular Biochemistry: Emerging Concepts and Networks. Open Biol.9 (8), 190126. 10.1098/rsob.190126
4
ArcosJ.DiangeloL. E.ScordoJ. M.SasindranS. J.MolivaJ. I.TurnerJ.et al (2015). Lung Mucosa Lining Fluid Modification ofMycobacterium Tuberculosisto Reprogram Human Neutrophil Killing Mechanisms. J. Infect. Dis.212 (6), 948–958. 10.1093/infdis/jiv146
5
ArcosJ.SasindranS. J.FujiwaraN.TurnerJ.SchlesingerL. S.TorrellesJ. B. (2011). Human Lung Hydrolases DelineateMycobacterium Tuberculosis-Macrophage Interactions and the Capacity to Control Infection. J.I.187 (1), 372–381. 10.4049/jimmunol.1100823
6
ArcosJ.SasindranS. J.MolivaJ. I.ScordoJ. M.SidikiS.GuoH.et al (2017). Mycobacterium tuberculosis Cell wall Released Fragments by the Action of the Human Lung Mucosa Modulate Macrophages to Control Infection in an IL-10-dependent Manner. Mucosal Immunol.10 (5), 1248–1258. 10.1038/mi.2016.115
7
ArnettE.WeaverA. M.WoodyardK. C.MontoyaM. J.LiM.HoangK. V.et al (2018). PPARγ Is Critical for Mycobacterium tuberculosis Induction of Mcl-1 and Limitation of Human Macrophage Apoptosis. Plos Pathog.14 (6), e1007100. 10.1371/journal.ppat.1007100
8
BarkawayA.RolasL.JouliaR.BodkinJ.LennT.Owen-WoodsC.et al (2021). Age-related Changes in the Local Milieu of Inflamed Tissues Cause Aberrant Neutrophil Trafficking and Subsequent Remote Organ Damage. Immunity54 (7), 1494–1510. 10.1016/j.immuni.2021.04.025
9
BichiouH.BouabidC.RabhiI.Guizani-TabbaneL. (2021). Transcription Factors Interplay Orchestrates the Immune-Metabolic Response of Leishmania Infected Macrophages. Front. Cel. Infect. Microbiol.11, 660415. 10.3389/fcimb.2021.660415
10
BoudreauxS. P.DurenR. P.CallS. G.NguyenL.FreireP. R.NarayananP.et al (2019). Drug Targeting of NR4A Nuclear Receptors for Treatment of Acute Myeloid Leukemia. Leukemia33 (1), 52–63. 10.1038/s41375-018-0174-1
11
BougarneN.WeyersB.DesmetS. J.DeckersJ.RayD. W.StaelsB.et al (2018). Molecular Actions of PPARα in Lipid Metabolism and Inflammation. Endocr. Rev.39 (5), 760–802. 10.1210/er.2018-00064
12
BulutO.KilicG.Domínguez-AndrésJ.NeteaM. G. (2020). Overcoming Immune Dysfunction in the Elderly: Trained Immunity as a Novel Approach. Int. Immunol.32 (12), 741–753. 10.1093/intimm/dxaa052
13
CananC. H.GokhaleN. S.CarruthersB.LafuseW. P.SchlesingerL. S.TorrellesJ. B.et al (2014). Characterization of Lung Inflammation and its Impact on Macrophage Function in Aging. J. Leukoc. Biol.96 (3), 473–480. 10.1189/jlb.4a0214-093rr
14
ChaliseH. N. (2019). Aging: Basic Concept. Am. J. Biomed. Sci. Res.1 (1), 8–10. 10.34297/ajbsr.2019.01.000503
15
ChiaC. W.EganJ. M.FerrucciL. (2018). Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk. Circ. Res.123 (7), 886–904. 10.1161/circresaha.118.312806
16
ChoS. J.Stout-DelgadoH. W. (2020). Aging and Lung Disease. Annu. Rev. Physiol.82, 433–459. 10.1146/annurev-physiol-021119-034610
17
CisnerosB.García-AguirreI. (2020). Nuclear Protein export Pathway in Aging Therapeutics. Aging12 (6), 4682–4684. 10.18632/aging.102948
18
DaviesL. C.TaylorP. R. (2015). Tissue‐resident Macrophages: Then and Now. Immunology144 (4), 541–548. 10.1111/imm.12451
19
De BosscherK.Vanden BergheW.HaegemanG. (2006). Cross-talk between Nuclear Receptors and Nuclear Factor κB. Oncogene25 (51), 6868–6886. 10.1038/sj.onc.1209935
20
DennisE. A.NorrisP. C. (2015). Eicosanoid Storm in Infection and Inflammation. Nat. Rev. Immunol.15 (8), 511–523. 10.1038/nri3859
21
DhimanV. K.BoltM. J.WhiteK. P. (2018). Nuclear Receptors in Cancer - Uncovering New and Evolving Roles through Genomic Analysis. Nat. Rev. Genet.19 (3), 160–174. 10.1038/nrg.2017.102
22
DuezH.PourcetB. (2021). Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway. Front. Endocrinol.12, 630536. 10.3389/fendo.2021.630536
23
DuongL.RadleyH.LeeB.DyeD.PixleyF.GroundsM.et al (2021). Macrophage Function in the Elderly and Impact on Injury Repair and Cancer. Immun. Ageing18 (1), 4. 10.1186/s12979-021-00215-2
24
DyerC. (2012). The Interaction of Ageing and Lung Disease. Chron. Respir. Dis.9 (1), 63–67. 10.1177/1479972311433766
25
FranceschiC.BonafèM.ValensinS.OlivieriF.De LucaM.OttavianiE.et al (2000). Inflamm-aging. An Evolutionary Perspective on Immunosenescence. Ann. N. Y Acad. Sci.908, 244–254. 10.1111/j.1749-6632.2000.tb06651.x
26
FrascaD.BlombergB. B.GarciaD.KeilichS. R.HaynesL. (2020). Age‐related Factors that Affect B Cell Responses to Vaccination in Mice and Humans. Immunol. Rev.296 (1), 142–154. 10.1111/imr.12864
27
FrascaD.BlombergB. B. (2016). Inflammaging Decreases Adaptive and Innate Immune Responses in Mice and Humans. Biogerontology17 (1), 7–19. 10.1007/s10522-015-9578-8
28
FroniusM.ClaussW. G.AlthausM. (2012). Why Do We Have to Move Fluid to Be Able to Breathe?Front. Physio.3, 146. 10.3389/fphys.2012.00146
29
FulopT.LarbiA.DupuisG.Le PageA.FrostE. H.CohenA. A.et al (2017). Immunosenescence and Inflamm-Aging as Two Sides of the Same Coin: Friends or Foes?Front. Immunol.8, 1960. 10.3389/fimmu.2017.01960
30
FülöpT.Jr.GagnéD.GouletA.-C.DesgeorgesS.LacombeG.ArcandM.et al (1999). Age-related Impairment of P56lck and ZAP-70 Activities in Human T Lymphocytes Activated through the TcR/CD3 Complex. Exp. Gerontol.34 (2), 197–216. 10.1016/s0531-5565(98)00061-8
31
FulopT.LarbiA.DouziechN.FortinC.GuérardK.-P.LesurO.et al (2004). Signal Transduction and Functional Changes in Neutrophils with Aging. Aging Cell3 (4), 217–226. 10.1111/j.1474-9728.2004.00110.x
32
Gómez-SerranoM.CamafeitaE.LoureiroM.PeralB. (2018). Mitoproteomics: Tackling Mitochondrial Dysfunction in Human Disease. Oxid Med. Cel Longev2018, 1435934. 10.1155/2018/1435934
33
GoplenN. P.WuY.SonY. M.LiC.WangZ.CheonI. S.et al (2020). Tissue-resident CD8+ T Cells Drive Age-Associated Chronic Lung Sequelae after Viral Pneumonia. Sci. Immunol.5 (53). 10.1126/sciimmunol.abc4557
34
GoplenN. P.CheonI. S.SunJ. (2021). Age-Related Dynamics of Lung-Resident Memory CD8+ T Cells in the Age of COVID-19. Front. Immunol.12, 636118. 10.3389/fimmu.2021.636118
35
GuiradoE.RajaramM. V.ChawlaA.DaigleJ.La PerleK. M.ArnettE.et al (2018). Deletion of PPARγ in Lung Macrophages Provides an Immunoprotective Response against M. tuberculosis Infection in Mice. Tuberculosis111, 170–177. 10.1016/j.tube.2018.06.012
36
GuthA. M.JanssenW. J.BosioC. M.CrouchE. C.HensonP. M.DowS. W. (2009). Lung Environment Determines Unique Phenotype of Alveolar Macrophages. Am. J. Physiology-Lung Cell Mol. Physiol.296 (6), L936–L946. 10.1152/ajplung.90625.2008
37
HaasR. H. (2019). Mitochondrial Dysfunction in Aging and Diseases of Aging. Biology (Basel)8 (2). 10.3390/biology8020048
38
HagenM.DerudderE. (2020). Inflammation and the Alteration of B-Cell Physiology in Aging. Gerontology66 (2), 105–113. 10.1159/000501963
39
HakimF. T.GressR. E. (2007). Immunosenescence: Deficits in Adaptive Immunity in the Elderly. Tissue Antigens70 (3), 179–189. 10.1111/j.1399-0039.2007.00891.x
40
HanS.YangK.OzenZ.PengW.MarinovaE.KelsoeG.et al (2003). Enhanced Differentiation of Splenic Plasma Cells but Diminished Long-Lived High-Affinity Bone Marrow Plasma Cells in Aged Mice. J. Immunol.170 (3), 1267–1273. 10.4049/jimmunol.170.3.1267
41
HarpurC. M.Le PageM. A.TateM. D. (2021). Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity. Virulence12 (1), 1629–1646. 10.1080/21505594.2021.1939608
42
HaynesL. (2020). Aging of the Immune System: Research Challenges to Enhance the Health Span of Older Adults. Front. Aging1, 1–2. 10.3389/fragi.2020.602108
43
HaynesL.SwainS. L. (2012). Aged-related Shifts in T Cell Homeostasis lead to Intrinsic T Cell Defects. Semin. Immunol.24 (5), 350–355. 10.1016/j.smim.2012.04.001
44
HazeldineJ.HarrisP.ChappleI. L.GrantM.GreenwoodH.LiveseyA.et al (2014). Impaired Neutrophil Extracellular Trap Formation: a Novel Defect in the Innate Immune System of Aged Individuals. Aging Cell13 (4), 690–698. 10.1111/acel.12222
45
HazeldineJ.LordJ. M. (2013). The Impact of Ageing on Natural Killer Cell Function and Potential Consequences for Health in Older Adults. Ageing Res. Rev.12 (4), 1069–1078. 10.1016/j.arr.2013.04.003
46
HillP. J.ScordoJ. M.ArcosJ.KirkbyS. E.WewersM. D.WozniakD. J.et al (2017). Modifications of Pseudomonas aeruginosa Cell Envelope in the Cystic Fibrosis Airway Alters Interactions with Immune Cells. Sci. Rep.7 (1), 4761. 10.1038/s41598-017-05253-9
47
HoeksemaM. A.GlassC. K. (2019). Nature and Nurture of Tissue-specific Macrophage Phenotypes. Atherosclerosis281, 159–167. 10.1016/j.atherosclerosis.2018.10.005
48
HuangW.GlassC. K. (2010). Nuclear Receptors and Inflammation Control: Molecular Mechanisms and Pathophysiological Relevance. Atvb30 (8), 1542–1549. 10.1161/atvbaha.109.191189
49
IddirM.BritoA.DingeoG.Fernandez Del CampoS. S.SamoudaH.La FranoM. R.et al (2020). Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients12 (6). 10.3390/nu12061562
50
IngramT.ChakrabartiL. (2016). Proteomic Profiling of Mitochondria: what Does it Tell Us about the Ageing Brain?Aging8 (12), 3161–3179. 10.18632/aging.101131
51
JanssensJ. P.PacheJ. C.NicodL. P. (1999). Physiological Changes in Respiratory Function Associated with Ageing. Eur. Respir. J.13 (1), 197–205. 10.1034/j.1399-3003.1999.13a36.x
52
JonesD. P.ModyV. C.Jr.CarlsonJ. L.LynnM. J.SternbergP.Jr. (2002). Redox Analysis of Human Plasma Allows Separation of Pro-oxidant Events of Aging from Decline in Antioxidant Defenses. Free Radic. Biol. Med.33 (9), 1290–1300. 10.1016/s0891-5849(02)01040-7
53
KeilichS. R.BartleyJ. M.HaynesL. (2019). Diminished Immune Responses with Aging Predispose Older Adults to Common and Uncommon Influenza Complications. Cell Immunol.345, 103992. 10.1016/j.cellimm.2019.103992
54
KimS.-J.ChereshP.JablonskiR.WilliamsD.KampD. (2015). The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis. Ijms16 (9), 21486–21519. 10.3390/ijms160921486
55
KlepschV.MoschenA. R.TilgH.BaierG.Hermann-KleiterN. (2019). Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD. Front. Immunol.10, 1070. 10.3389/fimmu.2019.01070
56
LafuseW. P.RajaramM. V. S.WuQ.MolivaJ. I.TorrellesJ. B.TurnerJ.et al (2019). Identification of an Increased Alveolar Macrophage Subpopulation in Old Mice that Displays Unique Inflammatory Characteristics and Is Permissive toMycobacterium tuberculosisInfection. J.I.203 (8), 2252–2264. 10.4049/jimmunol.1900495
57
LeeJ. M.LeeY. K.MamroshJ. L.BusbyS. A.GriffinP. R.PathakM. C.et al (2011). A Nuclear-receptor-dependent Phosphatidylcholine Pathway with Antidiabetic Effects. Nature474 (7352), 506–510. 10.1038/nature10111
58
LeeN.ShinM. S.KangI. (2012). T-cell Biology in Aging, with a Focus on Lung Disease. Journals Gerontol. Ser. A: Biol. Sci. Med. Sci.67A (3), 254–263. 10.1093/gerona/glr237
59
Leopold WagerC. M.ArnettE.SchlesingerL. S. (2019). Macrophage Nuclear Receptors: Emerging Key Players in Infectious Diseases. Plos Pathog.15 (3), e1007585–e. 10.1371/journal.ppat.1007585
60
Leopold WagerC. M.ArnettE.SchlesingerL. S. (2019). Mycobacterium tuberculosis and Macrophage Nuclear Receptors: what We Do and Don't Know. Tuberculosis116, S98–S106. 10.1016/j.tube.2019.04.016
61
LiL.LiuY.ChenH.-z.LiF.-w.WuJ.-f.ZhangH.-k.et al (2015). Impeding the Interaction between Nur77 and P38 Reduces LPS-Induced Inflammation. Nat. Chem. Biol.11 (5), 339–346. 10.1038/nchembio.1788
62
LintonP. J.DorshkindK. (2004). Age-related Changes in Lymphocyte Development and Function. Nat. Immunol.5 (2), 133–139. 10.1038/ni1033
63
LiuG.SummerR. (2019). Cellular Metabolism in Lung Health and Disease. Annu. Rev. Physiol.81, 403–428. 10.1146/annurev-physiol-020518-114640
64
López-OtínC.BlascoM. A.PartridgeL.SerranoM.KroemerG. (2013). The Hallmarks of Aging. Cell153 (6), 1194–1217. 10.1016/j.cell.2013.05.039
65
LorenzoE. C.BartleyJ. M.HaynesL. (2018). The Impact of Aging on CD4+ T Cell Responses to Influenza Infection. Biogerontology19 (6), 437–446. 10.1007/s10522-018-9754-8
66
LoweryE. M.BrubakerA. L.KuhlmannE.KovacsE. J. (2013). The Aging Lung. Clin. Interv. Aging8, 1489–1496. 10.2147/CIA.S51152
67
MandardS.PatsourisD. (2013). Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors. PPAR Res.2013, 613864. 10.1155/2013/613864
68
MassudiH.GrantR.BraidyN.GuestJ.FarnsworthB.GuilleminG. J. (2012). Age-associated Changes in Oxidative Stress and NAD+ Metabolism in Human Tissue. PLoS One7 (7), e42357. 10.1371/journal.pone.0042357
69
MaueA. C.YagerE. J.SwainS. L.WoodlandD. L.BlackmanM. A.HaynesL. (2009). T-cell Immunosenescence: Lessons Learned from Mouse Models of Aging. Trends Immunol.30 (7), 301–305. 10.1016/j.it.2009.04.007
70
McElhaneyJ. E.KuchelG. A.ZhouX.SwainS. L.HaynesL. (2016). T-cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines. Front. Immunol.7, 41. 10.3389/fimmu.2016.00041
71
McMasterS. R.WilsonJ. J.WangH.KohlmeierJ. E. (2015). Airway-Resident Memory CD8 T Cells Provide Antigen-specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production. J.I.195 (1), 203–209. 10.4049/jimmunol.1402975
72
MichaeloudesC.BhavsarP. K.MumbyS.XuB.HuiC. K. M.ChungK. F.et al (2020). Role of Metabolic Reprogramming in Pulmonary Innate Immunity and its Impact on Lung Diseases. J. Innate Immun.12 (1), 31–46. 10.1159/000504344
73
MolivaJ. I.DuncanM. A.Olmo-FontánezA.AkhterA.ArnettE.ScordoJ. M.et al (2019). The Lung Mucosa Environment in the Elderly Increases Host Susceptibility to Mycobacterium tuberculosis Infection. J. Infect. Dis.220 (3), 514–523. 10.1093/infdis/jiz138
74
MolivaJ. I.RajaramM. V. S.SidikiS.SasindranS. J.GuiradoE.PanX. J.et al (2014). Molecular Composition of the Alveolar Lining Fluid in the Aging Lung. Age36 (3), 9633. 10.1007/s11357-014-9633-4
75
MurphyE.CreanD. (2015). Molecular Interactions between NR4A Orphan Nuclear Receptors and NF-Κb Are Required for Appropriate Inflammatory Responses and Immune Cell Homeostasis. Biomolecules5 (3), 1302–1318. 10.3390/biom5031302
76
NagyL.SzantoA.SzatmariI.SzélesL. (2012). Nuclear Hormone Receptors Enable Macrophages and Dendritic Cells to Sense Their Lipid Environment and Shape Their Immune Response. Physiol. Rev.92 (2), 739–789. 10.1152/physrev.00004.2011
77
NagyZ. S.CzimmererZ.SzantoA.NagyL. (2013). Pro-inflammatory Cytokines Negatively Regulate PPARγ Mediated Gene Expression in Both Human and Murine Macrophages via Multiple Mechanisms. Immunobiology218 (11), 1336–1344. 10.1016/j.imbio.2013.06.011
78
NaylorK.LiG.VallejoA. N.LeeW.-W.KoetzK.BrylE.et al (2005). The Influence of Age on T Cell Generation and TCR Diversity. J. Immunol.174 (11), 7446–7452. 10.4049/jimmunol.174.11.7446
79
NingL.LouX.ZhangF.XuG. (2019). Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease. Mediators Inflamm.2019, 2624941. 10.1155/2019/2624941
80
NiwaY.KasamaT.MiyachiY.KanohT. (1989). Neutrophil Chemotaxis, Phagocytosis and Parameters of Reactive Oxygen Species in Human Aging: Cross-Sectional and Longitudinal Studies. Life Sci.44 (22), 1655–1664. 10.1016/0024-3205(89)90482-7
81
NotterR. H. (2000). Lung Surfactants: Basic Science and Clinical Applications. New York: Marcel Dekker, 1–444.
82
O'NeillL. A. J.KishtonR. J.RathmellJ. (2016). A Guide to Immunometabolism for Immunologists. Nat. Rev. Immunol.16 (9), 553–565. 10.1038/nri.2016.70
83
OdegaardJ. I.Ricardo-GonzalezR. R.GoforthM. H.MorelC. R.SubramanianV.MukundanL.et al (2007). Macrophage-specific PPARγ Controls Alternative Activation and Improves Insulin Resistance. Nature447 (7148), 1116–1120. 10.1038/nature05894
84
OlsonW. J.JakicB.Hermann‐KleiterN. (2020). Regulation of the Germinal center Response by Nuclear Receptors and Implications for Autoimmune Diseases. FEBS J.287 (14), 2866–2890. 10.1111/febs.15312
85
OrenR.FarnhamA. E.SaitoK.MilofskyE.KarnovskyM. L. (1963). Metabolic Patterns in Three Types of Phagocytizing Cells. J. Cel Biol17, 487–501. 10.1083/jcb.17.3.487
86
OuyangQ.WagnerW. M.VoehringerD.WikbyA.KlattT.WalterS.et al (2003). Age-associated Accumulation of CMV-specific CD8+ T Cells Expressing the Inhibitory Killer Cell Lectin-like Receptor G1 (KLRG1). Exp. Gerontol.38 (8), 911–920. 10.1016/s0531-5565(03)00134-7
87
PaillasseM. R.de MedinaP. (2015). The NR4A Nuclear Receptors as Potential Targets for Anti-aging Interventions. Med. Hypotheses84 (2), 135–140. 10.1016/j.mehy.2014.12.003
88
PapiA.De CarolisS.BertoniS.StorciG.SceberrasV.SantiniD.et al (2014). PPARγ and RXR Ligands Disrupt the Inflammatory Cross-Talk in the Hypoxic Breast Cancer Stem Cells Niche. J. Cel. Physiol229 (11), 1595–1606. 10.1002/jcp.24601
89
PappA. C.AzadA. K.PietrzakM.WilliamsA.HandelmanS. K.IgoR. P.Jr.et al (2018). AmpliSeq Transcriptome Analysis of Human Alveolar and Monocyte-Derived Macrophages over Time in Response to Mycobacterium tuberculosis Infection. PLoS One13 (5), e0198221. 10.1371/journal.pone.0198221
90
PawelecG.DerhovanessianE.LarbiA. (2010). Immunosenescence and Cancer. Crit. Rev. Oncology/Hematology75 (2), 165–172. 10.1016/j.critrevonc.2010.06.012
91
PiergalliniT. J.TurnerJ. (2018). Tuberculosis in the Elderly: Why Inflammation Matters. Exp. Gerontol.105, 32–39. 10.1016/j.exger.2017.12.021
92
PiergalliniT. J.TurnerJ. (2018). Tuberculosis in the Elderly: Why Inflammation Matters. Exp. Gerontol.105, 32–39. 10.1016/j.exger.2017.12.021
93
PublicationsU. N. (2019). World Population Ageing 2019: Highlights2020. United Nations New York.
94
Pulakazhi VenuV. K.AlstonL.IftincaM.TsaiY.-C.StephensM.Warriyar K. V.V.et al (2021). Nr4A1 Modulates Inflammation-Associated Intestinal Fibrosis and Dampens Fibrogenic Signaling in Myofibroblasts. Am. J. Physiology-Gastrointestinal Liver Physiol.321 (3), G280–G297. 10.1152/ajpgi.00338.2019
95
RengaB.FrancisciD.D’AmoreC.SchiaroliE.CarinoA.BaldelliF.et al (2012). HIV-1 Infection Is Associated with Changes in Nuclear Receptor Transcriptome, Pro-inflammatory and Lipid Profile of Monocytes. BMC Infect. Dis.12, 274. 10.1186/1471-2334-12-274
96
RicoteM.GlassC. (2007). PPARs and Molecular Mechanisms of Transrepression. Biochim. Biophys. Acta (Bba) - Mol. Cel Biol. Lipids1771 (8), 926–935. 10.1016/j.bbalip.2007.02.013
97
RottinghausE. K.VesoskyB.TurnerJ. (2009). Interleukin-12 Is Sufficient to Promote Antigen-independent Interferon-Gamma Production by CD8 T Cells in Old Mice. Immunology128 (1 Suppl. l), e679–90. 10.1111/j.1365-2567.2009.03061.x
98
SantosR.UrsuO.GaultonA.BentoA. P.DonadiR. S.BologaC. G.et al (2017). A Comprehensive Map of Molecular Drug Targets. Nat. Rev. Drug Discov.16, 19–34. 10.1038/nrd.2016.230
99
SchenkelJ. M.FraserK. A.BeuraL. K.PaukenK. E.VezysV.MasopustD. (2014). Resident Memory CD8 T Cells Trigger Protective Innate and Adaptive Immune Responses. Science346 (6205), 98–101. 10.1126/science.1254536
100
SchneiderJ. L.RoweJ. H.Garcia-de-AlbaC.KimC. F.SharpeA. H.HaigisM. C. (2021). The Aging Lung: Physiology, Disease, and Immunity. Cell184 (8), 1990–2019. 10.1016/j.cell.2021.03.005
101
SchöttkerB.BrennerH.JansenE. H.GardinerJ.PeaseyA.KubínováR.et al (2015). Evidence for the Free Radical/oxidative Stress Theory of Ageing from the CHANCES Consortium: a Meta-Analysis of Individual Participant Data. BMC Med.13, 300. 10.1186/s12916-015-0537-7
102
ScordoJ. M.Aguillón-DuránG. P.AyalaD.Quirino-CerrilloA. P.Rodríguez-ReynaE.Mora-GuzmánF.et al (2021). A Prospective Cross-Sectional Study of Tuberculosis in Elderly Hispanics Reveals that BCG Vaccination at Birth Is Protective whereas Diabetes Is Not a Risk Factor. PLoS One16 (7), e0255194. 10.1371/journal.pone.0255194
103
ScordoJ. M.ArcosJ.KelleyH. V.DiangeloL.SasindranS. J.YoungminE.et al (2017). Mycobacterium tuberculosis Cell Wall Fragments Released upon Bacterial Contact with the Human Lung Mucosa Alter the Neutrophil Response to Infection. Front. Immunol.8, 307. 10.3389/fimmu.2017.00307
104
ScordoJ. M.Olmo-FontánezA. M.KelleyH. V.SidikiS.ArcosJ.AkhterA.et al (2019). The Human Lung Mucosa Drives Differential Mycobacterium tuberculosis Infection Outcome in the Alveolar Epithelium. Mucosal Immunol.12, 795–804. 10.1038/s41385-019-0156-2
105
Sekhar M.D.R. V. (2019). “Oxidation Damage Accumulation Aging Theory (The Novel Role of Glutathione),” in Encyclopedia of Gerontology and Population Aging. Editors Gu,D.DupreM. E. (Cham: Springer International Publishing), 1–9. 10.1007/978-3-319-69892-2_51-1
106
SharmaG.GoodwinJ. (2006). Effect of Aging on Respiratory System Physiology and Immunology. Clin. Interventions Aging1 (3), 253–260. 10.2147/ciia.2006.1.3.253
107
ShenoyA. T.MizgerdJ. P. (2021). Seedy CD8+ TRM Cells in Aging Lungs Drive Susceptibility to Pneumonia and Sequelae. Cell Mol Immunol18 (4), 787–789. 10.1038/s41423-020-00629-w
108
ShivshankarP.BoydA. R.Le SauxC. J.YehI.-T.OrihuelaC. J. (2011). Cellular Senescence Increases Expression of Bacterial Ligands in the Lungs and Is Positively Correlated with Increased Susceptibility to Pneumococcal Pneumonia. Aging Cell10 (5), 798–806. 10.1111/j.1474-9726.2011.00720.x
109
ShortK. R.BigelowM. L.KahlJ.SinghR.Coenen-SchimkeJ.RaghavakaimalS.et al (2005). Decline in Skeletal Muscle Mitochondrial Function with Aging in Humans. Proc. Natl. Acad. Sci.102 (15), 5618–5623. 10.1073/pnas.0501559102
110
SpeeckaertM. M.VanfraechemC.SpeeckaertR.DelangheJ. R. (2014). Peroxisome Proliferator-Activated Receptor Agonists in a Battle against the Aging Kidney. Ageing Res. Rev.14, 1–18. 10.1016/j.arr.2014.01.006
111
StauchK. L.PurnellP. R.VilleneuveL. M.FoxH. S. (2015). Proteomic Analysis and Functional Characterization of Mouse Brain Mitochondria during Aging Reveal Alterations in Energy Metabolism. Proteomics15 (9), 1574–1586. 10.1002/pmic.201400277
112
StoutR. D.JiangC.MattaB.TietzelI.WatkinsS. K.SuttlesJ. (2005). Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences. J. Immunol.175 (1), 342–349. 10.4049/jimmunol.175.1.342
113
ThomasE. T.GuppyM.StrausS. E.BellK. J. L.GlasziouP. (2019). Rate of normal Lung Function Decline in Ageing Adults: a Systematic Review of Prospective Cohort Studies. BMJ Open9 (6), e028150. 10.1136/bmjopen-2018-028150
114
ToapantaF. R.RossT. M. (2009). Impaired Immune Responses in the Lungs of Aged Mice Following Influenza Infection. Respir. Res.10, 112. 10.1186/1465-9921-10-112
115
TorrellesJ. B.SchlesingerL. S. (2017). Integrating Lung Physiology, Immunology, and Tuberculosis. Trends Microbiol.25 (8), 688–697. 10.1016/j.tim.2017.03.007
116
Ubaida-MohienC.LyashkovA.Gonzalez-FreireM.TharakanR.ShardellM.MoaddelR.et al (2019). Discovery Proteomics in Aging Human Skeletal Muscle Finds Change in Spliceosome, Immunity, Proteostasis and Mitochondria. Elife8, eLife.49874. 10.7554/eLife.49874
117
UhrlaubJ. L.PulkoV.DeFilippisV. R.BroeckelR.StreblowD. N.ColemanG. D.et al (2016). Dysregulated TGF-β Production Underlies the Age-Related Vulnerability to Chikungunya Virus. Plos Pathog.12 (10), e1005891. 10.1371/journal.ppat.1005891
118
UyemuraK.CastleS. C.MakinodanT. (2002). The Frail Elderly: Role of Dendritic Cells in the Susceptibility of Infection. Mech. Ageing Develop.123 (8), 955–962. 10.1016/s0047-6374(02)00033-7
119
van OostromS. H.EngelfrietP. M.VerschurenW. M. M.SchipperM.WoutersI. M.BoezenM.et al (2018). Aging-related Trajectories of Lung Function in the General Population-The Doetinchem Cohort Study. PLoS One13 (5), e0197250. 10.1371/journal.pone.0197250
120
Vaz FragosoC. A.LeeP. J. (2012). The Aging Lung. Journals Gerontol. Ser. A: Biol. Sci. Med. Sci.67A (3), 233–235. 10.1093/gerona/glr249
121
VesoskyB.FlahertyD. K.RottinghausE. K.BeamerG. L.TurnerJ. (2006). Age Dependent Increase in Early Resistance of Mice to Mycobacterium tuberculosis Is Associated with an Increase in CD8 T Cells that Are Capable of Antigen Independent IFN-γ Production. Exp. Gerontol.41 (11), 1185–1194. 10.1016/j.exger.2006.08.006
122
VesoskyB.FlahertyD. K.TurnerJ. (2006). Th1 Cytokines Facilitate CD8-T-Cell-Mediated Early Resistance to Infection with Mycobacterium tuberculosis in Old Mice. Infect. Immun.74 (6), 3314–3324. 10.1128/iai.01475-05
123
VesoskyB.RottinghausE. K.DavisC.TurnerJ. (2009). CD8 T Cells in Old Mice Contribute to the Innate Immune Response to Mycobacterium tuberculosis via Interleukin-12p70-dependent and Antigen-independent Production of Gamma Interferon. Infect. Immun.77 (8), 3355–3363. 10.1128/iai.00295-09
124
ViolaA.MunariF.Sánchez-RodríguezR.ScolaroT.CastegnaA. (2019). The Metabolic Signature of Macrophage Responses. Front. Immunol.10, 1462. 10.3389/fimmu.2019.01462
125
VoehringerD.KoschellaM.PircherH. (2002). Lack of Proliferative Capacity of Human Effector and Memory T Cells Expressing Killer Cell Lectinlike Receptor G1 (KLRG1). Blood100 (10), 3698–3702. 10.1182/blood-2002-02-0657
126
VuttaradhiV. K.EzhilI.RamaniD.KanumuriR.RaghavanS.BalasubramanianV.et al (2021). Inflammation-induced PELP1 Expression Promotes Tumorigenesis by Activating GM-CSF Paracrine Secretion in the Tumor Microenvironment. J. Biol. Chem.298 (1), 101406. 10.1016/j.jbc.2021.101406
127
WangL.NanayakkaraG.YangQ.TanH.DrummerC.SunY.et al (2017). A Comprehensive Data Mining Study Shows that Most Nuclear Receptors Act as Newly Proposed Homeostasis-Associated Molecular Pattern Receptors. J. Hematol. Oncol.10 (1), 168. 10.1186/s13045-017-0526-8
128
WenischC.PatrutaS.DaxböckF.KrauseR.HörlW. (2000). Effect of Age on Human Neutrophil Function. J. Leukoc. Biol.67 (1), 40–45. 10.1002/jlb.67.1.40
129
WongC. K.SmithC. A.SakamotoK.KaminskiN.KoffJ. L.GoldsteinD. R. (2017). Aging Impairs Alveolar Macrophage Phagocytosis and Increases Influenza-Induced Mortality in Mice. J.I.199 (3), 1060–1068. 10.4049/jimmunol.1700397
130
XuL.MaX.VermaN.PerieL.PendseJ.ShamlooS.et al (2020). PPARγ Agonists Delay Age-Associated Metabolic Disease and Extend Longevity. Aging Cell19 (11), e13267. 10.1111/acel.13267
131
YangL.CaoY.ZhaoJ.FangY.LiuN.ZhangY. (2019). Multidimensional Proteomics Identifies Declines in Protein Homeostasis and Mitochondria as Early Signals for Normal Aging and Age-Associated Disease in Drosophila*[S]. Mol. Cell Proteomics18 (10), 2078–2088. 10.1074/mcp.ra119.001621
132
ZhangC.ZhangB.ZhangX.SunG.SunX. (2020). Targeting Orphan Nuclear Receptors NR4As for Energy Homeostasis and Diabetes. Front. Pharmacol.11, 587457. 10.3389/fphar.2020.587457
133
ZhaoL.ZhouS.GustafssonJ. Å. (2019). Nuclear Receptors: Recent Drug Discovery for Cancer Therapies. Endocr. Rev.40 (5), 1207–1249. 10.1210/er.2018-00222
134
ZhaoL.GimpleR. C.YangZ.WeiY.GustafssonJ. A.ZhouS. (2020). Immunoregulatory Functions of Nuclear Receptors: Mechanisms and Therapeutic Implications. Trends Endocrinol. Metab.31 (2), 93–106. 10.1016/j.tem.2019.10.002
135
ZhouF.DrabschY.DekkerT. J. A.de VinuesaA. G.LiY.HawinkelsL. J. A. C.et al (2014). Nuclear Receptor NR4A1 Promotes Breast Cancer Invasion and Metastasis by Activating TGF-β Signalling. Nat. Commun.5, 3388. 10.1038/ncomms4388
136
ZollnerG.TraunerM. (2009). Nuclear Receptors as Therapeutic Targets in Cholestatic Liver Diseases. Br. J. Pharmacol.156 (1), 7–27. 10.1111/j.1476-5381.2008.00030.x
Summary
Keywords
aging, lung environment, oxidative stress, respiratory infections, tuberculosis
Citation
Torrelles JB, Restrepo BI, Bai Y, Ross C, Schlesinger LS and Turner J (2022) The Impact of Aging on the Lung Alveolar Environment, Predetermining Susceptibility to Respiratory Infections. Front. Aging 3:818700. doi: 10.3389/fragi.2022.818700
Received
19 November 2021
Accepted
03 January 2022
Published
19 January 2022
Volume
3 - 2022
Edited by
Laura Haynes, University of Connecticut, United States
Reviewed by
Erica C. Lorenzo, University of Connecticut, United States
Dominique Martin, University of Connecticut, United States
Updates
Copyright
© 2022 Torrelles, Restrepo, Bai, Ross, Schlesinger and Turner.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jordi B. Torrelles, jtorrelles@txbiomed.org; Blanca I. Restrepo, Blanca.I.Restrepo@uth.tmc.edu; Yidong Bai, BaiY@uthscsa.edu; Corinna Ross, cross@txbiomed.org; Larry S. Schlesinger, lschlesinger@txbiomed.org; Joanne Turner, joanneturner@txbiomed.org
† These authors have contributed equally to this work
This article was submitted to Aging and the Immune System, a section of the journal Frontiers in Aging
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.